| Ticker |
ORTX
|
| CIK | 0001748907 |
| SIC | 2836 |
| Sector | Manufacturing |
| Industry Category | Pharmaceutical Products |
| Industry Group | Biological Products, Except Diagnostic Substances |
| Address | 245 HAMMERSMITH ROAD, 3RD FLOOR, LONDON, X0, W6 8PW |
| Website | orchard-tx.com |
| Phone | 011-44-0-203-3846700 |
| CEO | Bobby Gaspar |
| Employees | 260 |
Our team will help you customize a package that meets the needs of your business.
Request a Consultation|
Standardized FinancialsdocsIntrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals. For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards. Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics: |
|||||||||||||||||||||
|
Income Statement
|
Balance Sheet
|
||||||||||||||||||||
|
Cash Flow Statement
|
Calculations
|
||||||||||||||||||||
|
Latest NewsdocsIntrinio provides up-to-date news articles on every US company from various sources. Here are several examples: |
Cell And Gene Therapy Market Expected to Expand at a Steady 2024-2031 | Novartis International AG, Pfizer, Inc.BURLINGAME, CALIFORNIA, UNITED STATE, April 18, 2024/ EINPresswire.com/-- Coherent Market Insights introduces new research on the Cell And Gene Therapy Market covering the micro level of analysis by competitors and key business segments. The report also focuses on market drivers, challenges, revenue growth, future roadmap, standardization, deployment models,... Orchard Therapeutics Outlines U.S. Launch Plans for Lenmeldy™ (atidarsagene autotemcel), the Only Approved Therapy for Children with Early-onset Metachromatic Leukodystrophy--Orchard Therapeutics, recently acquired by Kyowa Kirin with the goal of accelerating the delivery of new gene therapies to patients around the globe, today announced the details of its U.S. commercial launch of Lenmeldy™, formerly known as OTL-200, the first FDA- approved therapy for the treatment of children with pre-symptomatic late infantile,... Cell And Gene Therapy Market See Incredible Growth 2024-2031 with World's Top Players |Bluebird Bio, Inc, Pfizer, IncBURLINGAME, CALIFORNIA, UNITED STATES, March 19, 2024/ EINPresswire.com/-- The Latest Research Report on the Cell And Gene Therapy Market 2024 to 2031 delivers precise economic forecasts, global and country-level predictions, and comprehensive analyses. Moreover, this report evaluates the current state of the Cell And Gene Therapy industry, anticipates... Orchard Therapeutics Receives FDA Approval of Lenmeldy™ (atidarsagene autotemcel), the Only Therapy for Eligible Children with Early-onset Metachromatic Leukodystrophy in the U.S.--Orchard Therapeutics, recently acquired by Kyowa Kirin with the goal of accelerating the delivery of new gene therapies to patients around the globe, today announced the U.S. Food and Drug Administration has approved Lenmeldy™, formerly known as OTL-200, for the treatment of children with pre-symptomatic late infantile, pre-symptomatic early juvenile or... $46.5+ Billion Gene Therapy Market to Grow at 22.8% CAGR, Globally, by 2030 | Harnessing the Power of Gene EditingThe increasing number of approvals of gene therapies within North America and Europe are the major reasons for market growth.. PORTLAND, OREGON, UNITED STATES, March 13, 2024/ EINPresswire.com/--𝐈𝐧𝐜𝐫𝐞𝐚𝐬𝐞𝐢𝐧𝐭𝐡𝐞𝐩𝐫𝐞𝐯𝐚𝐥𝐞𝐧𝐜𝐞𝐨𝐟𝐜𝐡𝐫𝐨𝐧𝐢𝐜𝐝𝐢𝐬𝐨𝐫𝐝𝐞𝐫𝐬,𝐫𝐢𝐬𝐞𝐢𝐧𝐠𝐨𝐯𝐞𝐫𝐧𝐦𝐞𝐧𝐭𝐬𝐮𝐩𝐩𝐨𝐫𝐭,𝐚𝐧𝐝𝐞𝐭𝐡𝐢𝐜𝐚𝐥𝐚𝐜𝐜𝐞𝐩𝐭𝐚𝐧𝐜𝐞𝐨𝐟𝐠𝐞𝐧𝐞𝐭𝐡𝐞𝐫𝐚𝐩𝐲𝐟𝐨𝐫𝐜𝐚𝐧𝐜𝐞𝐫𝐭𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭𝐝𝐫𝐢𝐯𝐞𝐭𝐡𝐞𝐠𝐫𝐨𝐰𝐭𝐡𝐨𝐟𝐭𝐡𝐞𝐠𝐥𝐨𝐛𝐚𝐥𝐠𝐞𝐧𝐞𝐭𝐡𝐞𝐫𝐚𝐩𝐲𝐦𝐚𝐫𝐤𝐞𝐭.𝐎𝐧𝐭𝐡𝐞𝐨𝐭𝐡𝐞𝐫𝐡𝐚𝐧𝐝,𝐡𝐢𝐠𝐡𝐜𝐨𝐬𝐭𝐨𝐟𝐠𝐞𝐧𝐞𝐭𝐡𝐞𝐫𝐚𝐩𝐢𝐞𝐬𝐫𝐞𝐬𝐭𝐫𝐚𝐢𝐧𝐬𝐭𝐡𝐞𝐠𝐫𝐨𝐰𝐭𝐡𝐭𝐨𝐬𝐨𝐦𝐞𝐞𝐱𝐭𝐞𝐧𝐭.𝐇𝐨𝐰𝐞𝐯𝐞𝐫,𝐭𝐡𝐞𝐩𝐫𝐞𝐬𝐞𝐧𝐜𝐞𝐨𝐟𝐚𝐝𝐯𝐚𝐧𝐜𝐞𝐝𝐡𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞𝐢𝐧𝐟𝐫𝐚𝐬𝐭𝐫𝐮𝐜𝐭𝐮𝐫𝐞𝐢𝐬𝐚𝐧𝐭𝐢𝐜𝐢𝐩𝐚𝐭𝐞𝐝𝐭𝐨𝐩𝐚𝐯𝐞𝐭𝐡𝐞𝐰𝐚𝐲𝐟𝐨𝐫𝐥𝐮𝐜𝐫𝐚𝐭𝐢𝐯𝐞𝐨𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬𝐢𝐧𝐭𝐡𝐞𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲. Allied Market Research published a report, titled,“ Gene Therapy Market by Vector Type, by Therapy, by Gene Type, by Application: Global Opportunity Analysis and Industry... |
